IP Library Granted Patent US 7,199,236
Granted Patent B2
US 7,199,236 · App. 10/940,360 · Granted Apr 3, 2007

Process for the synthesis of oligomeric compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,199,236
App. No.
10/940,360
Granted
Apr 3, 2007
Kind
B2
Abstract

Synthetic processes are provided wherein oligomeric compounds are prepared having phosphodiester, phosphorothioate, phosphorodithioate, or other covalent linkages. The oligomers have substantially reduced exocyclic adducts deriving from acrylonitrile or related contaminants.

Claims (21)

1. A method for deprotecting a solid-support bound oligonucleotide 15 to 25 nucleotides in length and containing 2-cyanoethyl-protected phosphate internucleotide linkages, the method comprising the step of:

reacting the protected oligonucleotide with a deprotection reagent comprising at least one amine, the conjugate acid of said amine having a pKa of from about 8 to about 11, whereby protecting groups are removed from the oligonucleotide.

2. The method of claim 1 , wherein the amine is a sufficiently strong base to effect the removal of a substantial majority of the phosphorus protecting groups and insufficiently strong to cause deprotonation of the thymidine N 3 position.

3. The method of claim 1 , wherein the deprotection reagent comprises an aliphatic amine.

4. The method of claim 1 , wherein the deprotection reagent further comprises a scavenger molecule that reacts with acrylonitrile or acrylonitrile-like products of deprotection.

5. The method of claim 1 , wherein the deprotection reagent further comprises a ketone, a diethyl ester of acetaminomalonic acid, acetonitrile, or a haloalkyl solvent.

6. A method for deprotecting a phosphate-linked oligonucleotide, wherein said oligonucleotide is 15 to 25 nucleotides in length and has a plurality of protected phosphorus linkages of formula:

wherein:

each X is O or S;

R t is a phosphorus protecting group of formula:

—C(R 10 ) 2 —C(R 10 ) 2 —W or —C(R 10 ) 2 —(CH═CH) p —C(R 10 ) 2 —W

each R 10 is independently H or lower alkyl;

W is an electron withdrawing group;

p is 1 to 3;

comprising:

providing a sample containing a plurality of said phosphate-linked oligonucleotides, wherein at least one R t is —CH 2 CH 2 CN;

contacting said oligonucleotides with a deprotecting agent for a time and under conditions sufficient to remove substantially all of said R t groups from said oligonucleotides to form a plurality of deprotected oligomers, said deprotecting reagent comprising at least one aliphatic amine, the conjugate acid of said amine having a pKa of from about 8 to about 11, said deprotecting reagent optionally further comprising one or more solvents selected from the group consisting of haloalkyl solvents and cyanoalkyl solvents.

7. The method of claim 6 , wherein the amine is a sufficiently strong base to effect the removal of a substantial majority of the phosphorus protecting groups and insufficiently strong to cause deprotonation of the thymidine N 3 position.

8. The method of claim 6 , wherein the deprotection reagent comprises an aliphatic amine.

9. The method of claim 6 , wherein the deprotection reagent further comprises a scavenger molecule that reacts with acrylonitrile or acrylonitrile-like products of deprotection.

10. The method of claim 6 , wherein the deprotection reagent further comprises a ketone, a diethyl ester of acetaminomalonic acid, acetonitrile, or a haloalkyl solvent.

Assignments (1)
CHANGE OF NAME Recorded Jul 26, 2017
From: ISIS PHARMACEUTICALS, INC.
To: IONIS PHARMACEUTICALS, INC.
Reel/Frame 043341/0557 →